Literature DB >> 22421529

Cannabis exposure associated with weight reduction and β-cell protection in an obese rat model.

R-A Levendal1, D Schumann, M Donath, C L Frost.   

Abstract

The aim of this study was to investigate the effect of an organic cannabis extract on β-cell secretory function in an in vivo diet-induced obese rat model and determine the associated molecular changes within pancreatic tissue. Diet-induced obese Wistar rats and rats fed on standard pellets were subcutaneously injected with an organic cannabis extract or the vehicle over a 28-day period. The effect of diet and treatment was evaluated using the intraperitoneal glucose tolerance tests (IPGTTs) and qPCR analysis on rat pancreata harvested upon termination of the experiment. The cafeteria diet induced an average weight difference of 32g and an overall increase in body weight in the experimental groups occurred at a significantly slower rate than the control groups, irrespective of diet. Area under the curve for glucose (AUC(g)) in the obese group was significantly lower compared to the lean group (p<0.001), with cannabis treatment significantly reducing the AUC(g) in the lean group (p<0.05), and remained unchanged in the obese group, relative to the obese control group. qPCR analysis showed that the cafeteria diet induced down-regulation of the following genes in the obese control group, relative to lean controls: UCP2, c-MYC and FLIP. Cannabis treatment in the obese group resulted in up-regulation of CB1, GLUT2, UCP2 and PKB, relative to the obese control group, while c-MYC levels were down-regulated, relative to the lean control group. Treatment did not significantly change gene expression in the lean group. These results suggest that the cannabis extract protects pancreatic islets against the negative effects of obesity.
Copyright © 2012 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22421529     DOI: 10.1016/j.phymed.2012.02.001

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  10 in total

1.  Cannabidiol modulation of antinociceptive tolerance to Δ9-tetrahydrocannabinol.

Authors:  Nicholas Z Greene; Jenny L Wiley; Zhihao Yu; Brian H Clowers; Rebecca M Craft
Journal:  Psychopharmacology (Berl)       Date:  2018-09-20       Impact factor: 4.530

2.  Marijuana and body weight.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2014-07

3.  Associations Between Marijuana Use and Cardiovascular Risk Factors and Outcomes: A Systematic Review.

Authors:  Divya Ravi; Mehrnaz Ghasemiesfe; Deborah Korenstein; Thomas Cascino; Salomeh Keyhani
Journal:  Ann Intern Med       Date:  2018-01-23       Impact factor: 25.391

4.  Weight loss outcomes are not compromised in bariatric patients using cannabis.

Authors:  Estella Y Huang; Ryan C Broderick; Jonathan Z Li; Joaquin L Serra; Pranav Ahuja; Samantha Wu; Michael Genz; Eduardo Grunvald; David C Kunkel; Bryan J Sandler; Santiago Horgan; Garth R Jacobsen
Journal:  Surg Endosc       Date:  2022-07-21       Impact factor: 3.453

5.  Cannabis Extracts Affected Metabolic Syndrome Parameters in Mice Fed High-Fat/Cholesterol Diet.

Authors:  Tal Assa-Glazer; Jonathan Gorelick; Noa Sela; Abraham Nyska; Nirit Bernstein; Zecharia Madar
Journal:  Cannabis Cannabinoid Res       Date:  2020-09-02

6.  The effects of cannabis use on physical health: A co-twin control study.

Authors:  J Megan Ross; Jarrod M Ellingson; Maia J Frieser; Robin C Corley; Christian J Hopfer; Michael C Stallings; Sally J Wadsworth; Chandra A Reynolds; John K Hewitt
Journal:  Drug Alcohol Depend       Date:  2021-11-27       Impact factor: 4.492

7.  Associations Between Cannabis Use, Abdominal Fat Phenotypes and Insulin Traits.

Authors:  Charlotte E Stuart; Juyeon Ko; Gisselle C Alarcon Ramos; Andre E Modesto; Jaelim Cho; Maxim S Petrov
Journal:  J Clin Med Res       Date:  2020-06-04

8.  Novel CB1 receptor antagonist BAR-1 modifies pancreatic islet function and clinical parameters in prediabetic and diabetic mice.

Authors:  Lesly Nava-Molina; Toyokazu Uchida-Fuentes; Héctor Ramos-Tovar; Martha Fregoso-Padilla; Marco Aurelio Rodríguez-Monroy; Ana V Vega; Gabriel Navarrete-Vázquez; Erik Andrade-Jorge; Rafael Villalobos-Molina; Ricardo Ortiz-Ortega; Alonso Vilches-Flores
Journal:  Nutr Diabetes       Date:  2020-03-04       Impact factor: 5.097

9.  Marijuana use and risk of prediabetes and diabetes by middle adulthood: the Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  Michael P Bancks; Mark J Pletcher; Stefan G Kertesz; Stephen Sidney; Jamal S Rana; Pamela J Schreiner
Journal:  Diabetologia       Date:  2015-09-13       Impact factor: 10.460

Review 10.  Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol.

Authors:  Patrycja Bielawiec; Ewa Harasim-Symbor; Adrian Chabowski
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-04       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.